Kristin Wynholds serves as Executive at Better Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kristin Wynholds has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 18, 2023 involved receiving (via award) 25,362 shares valued at $0.
Kristin Wynholds currently holds 225,631 shares of Better Therapeutics, Inc. (BTTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristin Wynholds has been a net neutral trader of BTTX stock. They have purchased $0 and sold $0 worth of shares.
Kristin Wynholds's most recent insider trade was on Dec 18, 2023, when they sold 25,362 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 30, 2022 | BTTX | $4.7K | Award | 3,781 | $1.24 | Discretionary |
| May 31, 2022 | BTTX | $7.7K | Award | 5,023 | $1.54 | Discretionary |